My Bots Weblog

«NEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world. Rumsfeld served as Gilead (Research)'s chairman from 1997 until he joined the Bush administration in 2001, and he still holds a Gilead stake valued at between $5 million and $25 million, according to federal financial disclosures filed by Rumsfeld. The forms don't reveal the exact number of shares Rumsfeld owns, but in the past six months fears of a pandemic and the ensuing scramble for Tamiflu have sent Gilead's stock from $35 to $47. That's made the Pentagon chief, already one of the wealthiest members of the Bush cabinet, at least $1 million richer.»...
Source: http://money.cnn.com | Source Status Category: Stratégie d'Influence et de Contre-influence

«We bring to the attention of Global Research readers this important commentary by Dr.Joseph Mercola. The fundamental issue is who owns the intellectual property rights over Tamiflu. The media reports suggest that the Swiss pharmaceutical company Roche will make billions. While the drug is produced by Roche, it was developed by Gilead Sciences Inc.which owns the intellectual property rights. Gilead, which has maintained a low profile, has outsourced the production to Roche. Donald Rumsfeld was appointed Chairman of Gilead Sciences, Inc. in 1997, a position which he held in the years prior to becoming Secretary of Defense.in the Bush adminstration. Rumsfeld had been on the Board of Directors from the establishment of Gilead in 1987. As confirmed in a company press statement in 1997, Donald H. Rumsfeld assumed the position of Chairman, of GILEAD: : "Gilead is fortunate to have had Don Rumsfeld as a stalwart board member since the company's earliest days, and we are very pleased that he has accepted the Chairmanship," Dr. Riordan said. "He has played an important role in helping to build and steer the company. His broad experience in leadership positions in both industry and government will serve us well as Gilead continues to build its commercial presence." According to company statement: Gilead Science Inc "has been active in the development of inhibitors for the potential treatment and prevention of viral influenza and protease inhibitors for the potential treatment of HIV" "The Company's research and development efforts encompass three interrelated programs: small molecule antivirals, cardiovascular therapeutics and genetic code blockers for cancer and other diseases. Gilead's expertise in each of these areas has also resulted in the discovery and development of non-nucleotide product candidates, including neuraminidase inhibitors for the potential treatment and prevention of viral influenza and protease inhibitors for the potential treatment of HIV" Also find below an article published in the SF Chronicle, which points to the relationship between GILEAD and Roche in relation to the Rights over Tami Flu.»...
Source: http://www.globalresearch.ca | Source Status Category: Stratégie d'Influence et de Contre-influence

«Spain's agriculture minister dismissed fears bird flu sparking a global epidemic among humans as "science fiction", saying the virus currently only poses a threat to birds. "The idea of a pandemic among humans is something from science fiction," Spanish Agricultural Minister Elena Espinosa said on the private radio station Cadena Ser, as Europe braced for the further spread of the H5N1 strain of the bird flu, which has killed 60 people in Asia during the past three years. Outbreaks of the H5N1 strain have been confirmed in Romania and Turkey, while further tests are being conducted on a suspect case in Greece. Currently the bird flu is "solely and exclusively a veterinary problem," said Espinosa. Human infections in Asia were "in very specific poultry raising situations where the families lived with the chickens and infection was due to constant inhalation," Espinosa said. While H5N1 currently does not spread easily between people, many scientists fear that it may combine with seasonal influenza in humans, mutating into an easily transmissible form that could kill millions like in the 1918 influenza pandemic. However, Espinosa announced increased surveillance measures and that the stockpile of bird flu vaccine for chickens would be doubled to 10 million doses. She said a quarantine would be set up around any suspected bird flu outbreaks, with poultry in nearby areas receiving vaccinations. The Spanish government decided Tuesday to buy six to 10 million doses of anti-viral drugs for groups most at risk for human flu.»...
Source: http://www.breitbart.com | Source Status Category: Stratégie d'Influence et de Contre-influence

«À la fin du XIXe siècle émergeait une nouvelle énergie, l’électricité, qui allait contribuer à modifier en profondeur tant l’activité économique que la vie quotidienne, constituant l’un des éléments fondamentaux du système technique au sens de B. Gille [1978] sur le point de succéder au système fer-vapeur-charbon. Cette nouvelle énergie allait vite devenir un enjeu économique considérable. Celui qui parviendrait à imposer sa conception de ce que serait le réseau de production et de distribution de l’électricité pourrait s’y positionner de manière privilégiée. Deux grands noms de l’industrie américaine allaient s’affronter dans ce qui ressemble fort à la première grande bataille moderne pour un standard industriel, avec des armes qui ne sont pas si différentes de celles qui sont utilisées dans les guerres technologiques d’aujourd’hui.»...
Source: http://www.annales.org | Source Status Categories: Bibliographie,Stratégie d'Influence et de Contre-influence,Tendances